JJLBRO and Romvy E-Ticaret sold five male creams and sprays as unapproved new drugs on a website and Amazon.
What happened
FDA reviewed the website https://jjlbro.com/ and the company’s Amazon storefront in May 2026. FDA found five products—Men’s Foreskin Repair Gel, Size’Up Chrono Erect, Penile Health Cream, Men’s External Delayed Spray, and Men’s Penis XXL Care Cream—marketed with claims to treat phimosis or premature ejaculation and to change size, stamina, or other body functions. FDA says these are unapproved new drugs because there are no approved applications for them.
What FDA found
FDA says the five products are drugs because their labeling claims they treat conditions such as phimosis or premature ejaculation or affect body functions such as size or stamina.
FD&C Act section 201(g)(1), 21 U.S.C. 321(g)(1)FDA says the products are new drugs because they are not generally recognized as safe and effective and have no FDA-approved applications.
FD&C Act sections 201(p) and 505(a), 21 U.S.C. 321(p) and 355(a)FDA says selling or shipping these unapproved new drugs in interstate commerce violates the FD&C Act.
FD&C Act sections 301(d) and 505(a), 21 U.S.C. 331(d) and 355(a)
What FDA wants
FDA asks the company to send a written response to FDAAdvisory@fda.hhs.gov within 15 business days of receipt, with corrective steps, steps to prevent recurrence, and supporting documents, using reference number 729873.
Who should pay attention
- online sellers of male enhancement products
- marketplaces hosting drug or supplement storefronts
- brands and distributors sourcing sexual health creams and sprays
This is a summary. Read the original letter on fda.gov.